Travere Therapeutics Inc
NASDAQ:TVTX

  • LAST PRICE
    7.1400
  • TODAY'S CHANGE (%)
    -0.1300 (-1.7882%)
  • Bid / Lots
    7.1300/ 4
  • Ask / Lots
    7.1500/ 10
  • Open / Previous Close
    7.1600 / 7.2700
  • Day Range
    6.9700
    7.2400
  • 52 Week Range
    5.1200
    17.9550
  • Volume
    176,306

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 15, 2024

      Show headlines and story abstract

    • 5:00PM ET on Wednesday May 15, 2024 by GlobeNewswire
      Companies Mentioned: TVTX

    • 5:00PM ET on Wednesday May 15, 2024 by Dow Jones
      Companies Mentioned: TVTX

      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 51,500 shares of its common stock to five new employees, consisting of inducement stock options to purchase an aggregate of 25,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 26,500 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan ("2018 Plan"), but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).

    • 5:00PM ET on Wednesday May 15, 2024 by Dow Jones
      Companies Mentioned: TVTX

      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 51,500 shares of its common stock to five new employees, consisting of inducement stock options to purchase an aggregate of 25,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 26,500 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan ("2018 Plan"), but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).

Peers Headlines